New diabetes device put to the test in Real-World study

NCT ID NCT07197788

ENROLLING_BY_INVITATION Disease control Sponsor: Endogenex, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Aug 05, 2026 · Updated 4 times

Summary

This study looks at the safety and performance of the Endogenex System in 50 adults with type 2 diabetes. Participants previously received a sham (fake) procedure in an earlier study. The main goal is to track any serious side effects related to the device or procedure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Baker Heart and Diabetes Institute

    Melbourne, Victoria, 3004, Australia

  • Care Access

    Quincy, Massachusetts, 02169, United States

  • Care Access

    Raleigh, North Carolina, 27607, United States

  • Care Access

    Houston, Texas, 77054, United States

  • HCA Florida Mercy Hospital

    Miami, Florida, 33133, United States

  • NorthShore University Health System

    Evanston, Illinois, 60201, United States

  • Orlando Health

    Orlando, Florida, 32806, United States

  • Robert Wood Johnson Medical School

    New Brunswick, New Jersey, 08901, United States

  • St. Vincent's Hospital Melbourne

    Fitzroy, Victoria, 3065, Australia

  • The University of Texas Health Science Center at Houston

    Bellaire, Texas, 77401, United States

  • University of Alabama

    Birmingham, Alabama, 35205, United States

  • University of Texas Southwestern Medical School - William P. Clements Jr. University Hospital

    Dallas, Texas, 75235, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.